SCHEMBL19965828

SCHEMBL19965828

C=C/C(C)=C\C(=C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20274696 1.00
SCHEMBL12512910 0.81 ALDH1A1 (0.36)
SCHEMBL19087195 0.75
SCHEMBL2730981 0.75
SCHEMBL2730979 0.75
SCHEMBL13772769 0.74 ALDH1A1 (0.33)
SCHEMBL20816991 0.74
SCHEMBL20816992 0.74
SCHEMBL15990519 0.74
SCHEMBL17772221 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020185830-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2020-09-17 WO disclosed
EP-2796451-B1 HETEROCYCLE AMIDO ALKYLOXY SUBSTITUTED QUINAZOLINE DERIVATIVE AND USE THEREOF QIAN WEI (CN) 2018-08-01 EP disclosed
WO-2018049068-A1 N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE PLIANT THERAPEUTICS, INC. (US) 2018-03-15 WO disclosed